Radiotherapy & Oncology
Volume 89, Issue 1 , Pages 44-50 , October 2008

A phase II trial of low-dose gemcitabine and radiation alternated to cisplatin and 5-fluorouracil: An active and manageable regimen for stage IV squamous cell carcinoma of the head and neck

  • Marco Benasso

      Affiliations

    • Department of Medical Oncology A, National Institute for Cancer Research, Genoa, Italy
    • Corresponding Author InformationCorresponding author. Marco Benasso, S.C. Oncologia Medica A, National Institute for Cancer Research, Largo Rosanna Benzi, 10, 16132 Genova, Italy.
  • ,
  • Viviana Vigo

      Affiliations

    • Department of Medical Oncology A, National Institute for Cancer Research, Genoa, Italy
  • ,
  • Almalina Bacigalupo

      Affiliations

    • Department of Radiation Oncology, National Institute for Cancer Research, Genoa, Italy
  • ,
  • Anna Ponzanelli

      Affiliations

    • Department of Medical Oncology A, National Institute for Cancer Research, Genoa, Italy
  • ,
  • Michela Marcenaro

      Affiliations

    • Department of Radiation Oncology, National Institute for Cancer Research, Genoa, Italy
  • ,
  • Renzo Corvò

      Affiliations

    • Department of Otholaryngology, National Institute for Cancer Research, Genoa, Italy
  • ,
  • Giovanni Margarino

      Affiliations

    • Department of Otholaryngology, National Institute for Cancer Research, Genoa, Italy

Received 14 December 2007 ,Revised 13 March 2008 ,Accepted 1 April 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0167-8140(08)00196-5

doi: 10.1016/j.radonc.2008.04.002

Radiotherapy & Oncology
Volume 89, Issue 1 , Pages 44-50 , October 2008